Old Web
English
Sign In
Acemap
>
Paper
>
Intraperitoneal or subcutaneously administered IL-15 superagonist (N-803) increases NK cell cytotoxicity in ovarian cancer
Intraperitoneal or subcutaneously administered IL-15 superagonist (N-803) increases NK cell cytotoxicity in ovarian cancer
2020
Martin Felices
Laura Bendzick
Peter Hinderlie
Behiye Kodal
Erin Wesley
Jeffrey S. Miller
Melissa A. Geller
Keywords:
Ovarian cancer
Cancer research
NK Cell Cytotoxicity
Interleukin 15
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]